Uncover key drivers, emerging technologies, and competitive movements shaping the gastroesophageal reflux disease (gerd) market from 2026–2035 with trusted insights from The Business Research Company
What level of CAGR-driven expansion is anticipated in the Gastroesophageal Reflux Disease (GERD) Market between 2026 and 2030?
The gastroesophageal reflux disease (GERD) market size has shown steady growth in recent years. It is forecast to increase from $5.33 billion in 2025 to $5.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.3%. The expansion observed during the historic period is attributable to the widespread utilization of antacids and H2 blockers, an increasing prevalence of obesity, high consumption rates of processed foods, enhanced clinical diagnosis rates, and the availability of generic PPIs.
The market size for gastroesophageal reflux disease (GERD) is poised for consistent expansion over the coming years, forecast to reach $6.2 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.3%. This projected growth throughout the forecast period stems from factors including the rise in minimally invasive reflux procedures, the ongoing demand for long-term symptom management, continuous innovation in endoscopic devices, the increasing geriatric population, and greater patient awareness. Furthermore, significant trends expected during this period involve the rising long-term use of proton pump inhibitors, enhanced adoption of minimally invasive GERD procedures, a growing recognition of lifestyle-based disease management, the expansion of endoscopic treatment options, and elevated diagnosis rates achieved through improved screening protocols.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp
What Drivers Are Affecting Demand-Supply Dynamics In The Gastroesophageal Reflux Disease (GERD) Market?
The rising occurrence of esophageal diseases is anticipated to spur the expansion of the gastroesophageal reflux disease (GERD) market in the future. Esophageal diseases are medical conditions impacting the esophagus, the muscular tube that connects the mouth to the stomach. The goal of treating these conditions is to alleviate discomfort, improve daily living, and avoid complications, ultimately contributing to better health and wellness for those affected by gastroesophageal reflux disease. An illustration of this is found in January 2023, when the American Cancer Society, a US-based Professional organization, reported approximately 21,560 new cases of esophageal cancer diagnosed each year in the United States, alongside 16,120 deaths from esophageal cancer. Hence, the increasing prevalence of esophageal diseases is a key driver for the growth of the gastroesophageal reflux disease (GERD) market.
How Is The Gastroesophageal Reflux Disease (GERD) Market Organized Into Various Segments?
The gastroesophageal reflux disease (gerd) market covered in this report is segmented –
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty Clinics
Subsegments:
1) By Antacids: Calcium Carbonate, Magnesium Hydroxide, Aluminum Hydroxide
2) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole
3) By H2 Receptor Blockers: Ranitidine, Famotidine, Nizatidine, Cimetidine
4) By Prokinetic Agents: Metoclopramide, Domperidone
5) By Dopamine Receptor Antagonists: Prochlorperazine, Droperidol
Which Trends Are Influencing The Development Of The Gastroesophageal Reflux Disease (GERD) Market?
Major companies operating in the gastroesophageal reflux disease (GERD) market are prioritizing the introduction of innovative gastroesophageal reflux disease treatment devices to maintain their position. For instance, in April 2023, Laborie Medical Technologies, a US-based medical technology firm, unveiled the new alpHaONE wireless pH-capsule reflux testing diagnostic system, engineered for diagnosing gastroesophageal reflux disease (GERD). This system offers up to 96 hours of monitoring data and boasts a compact design with expanded buttons and a fail-safe capsule delivery mechanism. Furthermore, the system incorporates a software application featuring a virtual instruction program and user-customizable symptom buttons to enhance the user experience.
Who Are The Primary Competitors In The Global Gastroesophageal Reflux Disease (GERD) Market?
Major companies operating in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Gastroesophageal Reflux Disease (GERD) Market In The Coming Years?
North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease (gerd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Gastroesophageal Reflux Disease (GERD) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12917&type=smp
Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease (GERD) Market 2026, By The Business Research Company
Barretts Esophagus Market Report 2026
https://www.thebusinessresearchcompany.com/report/barretts-esophagus-global-market-report
Gastroesophageal Reflux Disease Therapeutics Market Report 2026
Gastroparesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model